Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Camphausen

Showing results (1-10 of 258) with videos related to

Pageof 26
Sort By:
Seminars in Radiation Oncology|May 26, 2009
Seminars in Radiation Oncology. IntroductionKevin Camphausen
Cell Cycle (Georgetown, Tex.)|December 4, 2002
Portrait of an editorial board member: Judah Folkman: the father of modern angiogenesisKevin Camphausen
Medrxiv : the Preprint Server for Health Sciences|January 29, 2026
Phase II Trial Evaluating the Association of Peripheral Blood Immunologic Response to Therapeutic Response After Adjuvant Treatment with Immune Checkpoint Inhibition (ICI) in Patients with Newly Diagnosed Glioblastoma or Gliosarcoma, Kevin Camphausen
Journal of Cancer Clinical Trials|November 26, 2016
Mitotic Protein Kinase 1: Role in Spindle Assembly Checkpoint RevisitedAnita Tandle, Kevin Camphausen
Expert Opinion on Biological Therapy|June 25, 2002
Angiogenesis inhibitors and radiotherapy of primary tumoursKevin Camphausen, Cynthia Menard
Cancer Treatment and Research|February 2, 2008
Advancement of antiangiogenic and vascular disrupting agents combined with radiationDeborah Citrin, Kevin Camphausen
Expert Review of Anticancer Therapy|October 16, 2004
Optical imaging of mice in oncologic researchDeborah Citrin, Kevin Camphausen
Radiation Research|October 7, 2016
State-of-the-Art Advances in Radiation Biodosimetry for Mass Casualty Events Involving Radiation ExposureMary Sproull, Kevin Camphausen
Expert Review of Anticancer Therapy|June 25, 2003
Angiogenic tumor markers, antiangiogenic agents and radiation therapyLinda W Chan, Kevin Camphausen
Oncology (Williston Park, N.Y.)|April 6, 2010
HDAC inhibitors in cancer carePhilip J Tofilon, Kevin Camphausen
Pageof 26

Showing results (1-10 of 258) with videos related to

Sort By:
Pageof 26
Seminars in Radiation Oncology|May 26, 2009
Seminars in Radiation Oncology. IntroductionKevin Camphausen
Cell Cycle (Georgetown, Tex.)|December 4, 2002
Portrait of an editorial board member: Judah Folkman: the father of modern angiogenesisKevin Camphausen
Medrxiv : the Preprint Server for Health Sciences|January 29, 2026
Phase II Trial Evaluating the Association of Peripheral Blood Immunologic Response to Therapeutic Response After Adjuvant Treatment with Immune Checkpoint Inhibition (ICI) in Patients with Newly Diagnosed Glioblastoma or Gliosarcoma, Kevin Camphausen
Journal of Cancer Clinical Trials|November 26, 2016
Mitotic Protein Kinase 1: Role in Spindle Assembly Checkpoint RevisitedAnita Tandle, Kevin Camphausen
Expert Opinion on Biological Therapy|June 25, 2002
Angiogenesis inhibitors and radiotherapy of primary tumoursKevin Camphausen, Cynthia Menard
Cancer Treatment and Research|February 2, 2008
Advancement of antiangiogenic and vascular disrupting agents combined with radiationDeborah Citrin, Kevin Camphausen
Expert Review of Anticancer Therapy|October 16, 2004
Optical imaging of mice in oncologic researchDeborah Citrin, Kevin Camphausen
Radiation Research|October 7, 2016
State-of-the-Art Advances in Radiation Biodosimetry for Mass Casualty Events Involving Radiation ExposureMary Sproull, Kevin Camphausen
Expert Review of Anticancer Therapy|June 25, 2003
Angiogenic tumor markers, antiangiogenic agents and radiation therapyLinda W Chan, Kevin Camphausen
Oncology (Williston Park, N.Y.)|April 6, 2010
HDAC inhibitors in cancer carePhilip J Tofilon, Kevin Camphausen
Pageof 26